KI Supplements publishes papers on increasing access to integrated ESKD care worldwide
Kidney International Supplements (KIS) has published a set of papers describing the background, rationale, and action plans for developing a strategic approach to increase access to integrated end-stage kidney disease (ESKD) care worldwide over the next decade. Read this special edition here. Following March 2018's second Global Kidney Health Summit organised by the International Society of Nephrology (ISN), the primary...